GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the N-terminal half of the tfiih subunit P52

Analyse Crystal structure of the N-terminal half of the tfiih subunit P52 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6TRU
Type
protein
Length
1,082 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA polymerase II transcription factor B subunit 2
UniProt
G0S965
Pockets
20 · best druggability 0.73

Structure

x-ray diffraction · 4 distinct chains · 58% helix, 6% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BRNA polymerase II transcription factor B subunit 2protein28057% helix, 7% strandG0S965
ARNA polymerase II transcription factor B subunit 2protein27556% helix, 7% strandG0S965
CRNA polymerase II transcription factor B subunit 2protein26359% helix, 5% strandG0S965
DRNA polymerase II transcription factor B subunit 2protein26459% helix, 6% strandG0S965

Pockets

20 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12250.730.8847empty
24800.710.8051empty
31090.660.8924empty
41820.660.8540empty
51440.630.8532empty

Interfaces

5 interfaces between chains.

  • B–A · 1308 Ų buried · 7 hydrogen bonds · protein-protein
  • C–D · 1141 Ų buried · 7 hydrogen bonds · protein-protein
  • A–C · 368 Ų buried · 2 hydrogen bonds · protein-protein
  • B–C · 262 Ų buried · 5 hydrogen bonds · protein-protein
  • A–D · 151 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 6TRU · Crystal structure of the N-terminal half of the TFIIH subunit p52 · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.